References
Casulo C, Byrtek M, Dawson KL, Zhou X, Farber CM, Flowers CR, Hainsworth JD, Maurer MJ, Cerhan JR, Link BK, Zelenetz AD, Friedberg JW (2015) Early relapse of follicular lymphoma after rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone defines patients at high risk for death: an analysis from the national lympho care study. J Clin Oncol 33(23):2516–2522. https://doi.org/10.1200/JCO.2014.59.7534
Sorigue M, Mercadal S, Alonso S, Fernández-Álvarez R, García O, Moreno M, Pomares H, Alcoceba M, González-García E, Motlló C, González-Barca E, Martin A, Sureda A, Caballero D, Ribera JM, Sancho JM (2017) Refractoriness to immunochemotherapy in follicular lymphoma: predictive factors and outcome. Hematol Oncol (in press. https://doi.org/10.1002/hon.2378.
Solal-Céligny P, Roy P, Colombat P, White J, Armitage JO, Arranz-Saez R, Au WY, Bellei M, Brice P, Caballero D, Coiffier B, Conde-Garcia E, Doyen C, Federico M, Fisher RI, Garcia-Conde JF, Guglielmi C, Hagenbeek A, Haïoun C, LeBlanc M, Lister AT, Lopez-Guillermo A, McLaughlin P, Milpied N, Morel P, Mounier N, Proctor SJ, Rohatiner A, Smith P, Soubeyran P, Tilly H, Vitolo U, Zinzani PL, Zucca E, Montserrat E (2004) Follicular lymphoma international prognostic index. Blood 104(5):1258–1265. https://doi.org/10.1182/blood-2003-12-4434
Perea G, Altés A, Montoto S, López-Guillermo A, Domingo-Doménech E, Fernández-Sevilla A, Ribera JM, Grau J, Pedro C, Angel Hernández J, Estany C, Briones J, Martino R, Sureda A, Sierra J, Montserrat E (2005) Prognostic indexes in follicular lymphoma: a comparison of different prognostic systems. Ann Oncol 16(9):1508–1513. https://doi.org/10.1093/annonc/mdi269
Meignan M, Cottereau AS, Versari A, Chartier L, Dupuis J, Boussetta S, Grassi I, Casasnovas RO, Haioun C, Tilly H, Tarantino V, Dubreuil J, Federico M, Salles G, Luminari S, Trotman J (2016) Baseline metabolic tumor volume predicts outcome in high-tumor-burden follicular lymphoma: a pooled analysis of three multicenter studies. J Clin Oncol 34(30):3618–3626. https://doi.org/10.1200/JCO.2016.66.9440
Pastore A, Jurinovic V, Kridel R, Hoster E, Staiger AM, Szczepanowski M, Pott C, Kopp N, Murakami M, Horn H, Leich E, Moccia AA, Mottok A, Sunkavalli A, Van Hummelen P, Ducar M, Ennishi D, Shulha HP, Hother C, Connors JM, Sehn LH, Dreyling M, Neuberg D, Möller P, Feller AC, Hansmann ML, Stein H, Rosenwald A, Ott G, Klapper W, Unterhalt M, Hiddemann W, Gascoyne RD, Weinstock DM, Weigert O (2015) Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry. Lancet Oncol 16(9):1111–1122. https://doi.org/10.1016/S1470-2045(15)00169-2
Federico M, Bellei M, Marcheselli L, Luminari S, Lopez-Guillermo A, Vitolo U, Pro B, Pileri S, Pulsoni A, Soubeyran P, Cortelazzo S, Martinelli G, Martelli M, Rigacci L, Arcaini L, Di Raimondo F, Merli F, Sabattini E, McLaughlin P, Solal-Céligny P (2009) Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project. J Clin Oncol 27(27):4555–4562. https://doi.org/10.1200/JCO.2008.21.3991
Funding
Supported in part by: RD12/0036/0029 del Instituto de Salud Carlos III, Ministerio de Economía y Competitividad, Red Temática de Investigación Cooperativa en Cáncer (RTICC, FEDER); SGR225 (GRE) Generalitat de Catalunya; ayuda económica de la Fundació Internacional Josep Carreras y de la fundación “La Caixa”.
Author information
Authors and Affiliations
Contributions
MS and JMS designed the study, analyzed the data, and wrote the manuscript. SM, SA, RFA, and JMS recruited patients.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest
Electronic supplementary material
ESM 1
(DOC 187 kb)
Rights and permissions
About this article
Cite this article
Sorigue, M., Mercadal, S., Alonso, S. et al. Is there a role for the international prognostic index in follicular lymphoma?. Ann Hematol 97, 713–715 (2018). https://doi.org/10.1007/s00277-017-3197-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-017-3197-1